Tero Aittokallio

JAK1/2 and BCL2 Inhibitors Synergize to Counter-Act Bone Marrow Stromal Cell-Induced Protection of AML (2015)

Blood

Karjalalainen R, Pemovska T, Majumder MM, Yadav B, Tang J, Kontro M, Gjertsen B, Parsons A, Suvela M, Porkka K, Aittokallio T, Kallioniemi O, Wennerberg K, Knowles J, Heckman C

(Muu (O2))

Identification of drug candidates and repurposing opportunities through compound-target interaction networks (2015)

Expert Opinion on Drug Discovery

Anna Cichonska, Juho Rousu, Tero Aittokallio

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells from ascites (2015)

Cancer Research

Murumagi A, Hirasawa A, Arjama M, Valimaki K, Yadav B, Tang J, Szwajda A, Turunen L, Mpindi JP, Pellinen T, Wennerberg K, Butzow R, Aittokallio T, Kallioniemi I

(Muu (O2))

Dasatinib and everolimus show synergistic growth inhibition with paclitaxel in an ovarian granulosa cell tumor model (2015)

Cancer Research

Haltia UM, Andersson N, Yadav B, Kulesskiy E, Farkkila A, Riska A, Unkila-Kallio L, Wennerberg K, Aittokallio T, Anttonen M

(Muu (O2))

Identification of subgroups of triple negative breast cancer cells with selective responses to mTOR, CDK, mitotic and proteasome inhibitors (2015)

Cancer Research

Gautam P, Karhinen L, Szwajda A, Jha SK, Yadav B, Aittokallio T, Wennerberg K

(Muu (O2))

Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling (2015)

Scientific Reports

Otto Kauko, Teemu Daniel Laajala, Mikael Jumppanen, Petteri Hintsanen, Veronika Suni, Pekka Haapaniemi, Garry Corthals, Tero Aittokallio, Jukka Westermarck, Susumu Y. Imanishi

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

What is synergy? The Saariselka agreement revisited (2015)

Frontiers in Pharmacology

Tang J, Wennerberg K, Aittokallio T

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Toward more realistic drug-target interaction predictions (2015)

Briefings in Bioinformatics

Tapio Pahikkala, Antti Airola, Sami Pietilä, Sushil Shakyawar, Agnieszka Szwajda, Jing Tang, Tero Aittokallio

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Patient-derived prostate cancer cells for piloting of drug sensitivity and resistance testing (2015)

BJU International

Saeed K, Rahkama V, Eldfors S, Bychkov D, Mpindi JP, Yadav B, Paavolainen L, Aittokallio T, Wennerberg K, Peehl DM, Horvath P, Mirtti T, Rannikko A, Kallioniemi O, Ostling P, af Hallstrom TM

(Muu (O2))

Pro-apoptotic functions of AMPK revealed by Myc (2015)

Molecular Cancer Research

Haikala HM, Marques E, Eskelinen V, Viheriaranta-Nieminen A, Saarikoski S, Nevalaita L, Kovanen P, Heikkila P, Leidenius M, Laajala D, Aittokallio T, Munne P, Klefstrom J

(Muu (O2))

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

JAK1/2 and BCL2 Inhibitors Synergize to Counter-Act Bone Marrow Stromal Cell-Induced Protection of AML (2015)

Identification of drug candidates and repurposing opportunities through compound-target interaction networks (2015)

Novel therapeutic possibilities for chemorefractory ovarian cancer patients identified by functional ex vivo drug sensitivity testing of primary cells from ascites (2015)

Dasatinib and everolimus show synergistic growth inhibition with paclitaxel in an ovarian granulosa cell tumor model (2015)

Identification of subgroups of triple negative breast cancer cells with selective responses to mTOR, CDK, mitotic and proteasome inhibitors (2015)

Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling (2015)

What is synergy? The Saariselka agreement revisited (2015)

Toward more realistic drug-target interaction predictions (2015)

Patient-derived prostate cancer cells for piloting of drug sensitivity and resistance testing (2015)

Pro-apoptotic functions of AMPK revealed by Myc (2015)